(5 Aug 2021) The National Institute of Pharmaceutical Education and Research (NIPER-Kolkata) launched its own open access publishing hub with F1000, Taylor & Francis Group’s open research publishing arm. This will be hosted on the F1000Research site, adopting its pioneering approach to open science publishing.
NIPER-Kolkata, founded in 2007 as a centre of excellence for higher education, research and development in Pharmaceutical Sciences, will be adopting F1000’s open science practices to increase the reproducibility and accessibility of their published research. This means the research is free for anyone to read and will use the innovative F1000Research publishing model that combines the benefits of rapid publication with mechanisms to assure quality and transparency, thereby accelerating research impact.
The NIPER-Kolkata gateway provides a home for their conference-linked outputs, enabling their scientific outcomes to be published open access. This gateway welcomes submissions from the fields of, drug discovery, process chemistry, pharmacological studies, natural products, pharmaceutical formulation, computational studies, and medical devices, published in all forms, from traditional research articles, to a protocols, registered report, data notes, case studies, and much more.
The NIPER-Kolkata gateway is now open for submissions: https://f1000research.com/NIPER. Any article with a co-author at NIPER-Kolkata is eligible.
The press release in full is here.
